Survival benefit of high-dose therapy in poor-risk aggressive non-Hodgkin's lymphoma: concerns about omissions in the data presented.

Research output: Contribution to journalArticle

401 Citations (Scopus)
Original languageEnglish
Pages (from-to)1884-1884
Number of pages1
JournalJournal of Clinical Oncology : official journal of the American Society of Clinical Oncology
Volume19(6)
Publication statusPublished - 2001

Cite this